Latest Technology News

McLaren Minerals has successfully raised $1.282 million through a two-tranche placement to advance its McLaren Titanium Project in Western Australia, aiming to complete a critical pre-feasibility study by early Q3 2025.

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Brazilian Rare Earths has successfully produced high-purity mixed-rare-earth carbonate and uranium yellowcake from its Monte Alto Project, marking a key milestone in its integrated supply chain ambitions.

ACDC Metals has released a comprehensive scoping study for its Goschen Central project in Victoria, revealing strong economic potential through a two-phase heavy mineral sand and rare earth element operation. The study highlights robust financial metrics and strategic importance in critical minerals supply.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

Hastings Technology Metals appoints Vince Catania as CEO, entrusting him with advancing the Yangibana Rare Earths Project and broader portfolio development.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.

Service Stream Limited has locked in a significant $440 million contract with NBN Co to continue upgrading Australia’s fibre network, extending its role in the national infrastructure program.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.